Arkolith/Insider Trading/IMMX/Form 4

Morris Gabriel S

CFO, DirectorImmix Biopharma, Inc. (IMMX) · full profile →Form 4 · filed May 20, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2024Grant(A)24K——24K
May 20, 2024Grant(A)194K——280K
May 20, 2024Grant(A)24K——271K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-020776) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML